ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase ... (ross margin anticipated toexceed 40 perc...)

ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent

Date:9/9/2008

ross margin anticipated to exceed 40 percent and that operating expenses will be relatively comparable with fiscal 2008. As a result, management expects to exit the fourth fiscal quarter at break even.

Conference call details:

Dial-in (U.S.): 1-800-860-2442

Dial-in (International): 412-858-4600

Conference name: "ThermoGenesis"

To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

An audio replay of the conference call will be available beginning approximately two hours after completion of the call for the following five business days.

To access the replay:

Access number (U.S.): 1-877-344-7529

Access number (International): 412-317-0088

Conference ID#: 385107

THERMOGENESIS CORP.

Condensed Consolidated Balance Sheets

(Unaudited)

June 30, June 30,

2008 2007

ASSETS

Current assets:

Cash and cash equivalents $4,384,000 $5,730,000

Short term investments 20,903,000 27,649,000

Accounts receivable, net 5,976,000 3,226,000

Inventory 5,131,000 5,046,000

Other current assets 367,000 415,000

Total current assets 36,761,000 42,066,000

Equipment, net 1,450,000 1,602,000

Other assets 71,000 122,000

'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
7. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
8. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
9. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
10. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
11. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))

Post Your Comments:

ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase ...(ross margin anticipated toexceed 40 perc...)